Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ecopetrol SA

8.40
-0.1000-1.18%
Post-market: 8.400.00000.00%16:10 EDT
Volume:1.67M
Turnover:14.06M
Market Cap:17.27B
PE:5.15
High:8.52
Open:8.41
Low:8.37
Close:8.50
Loading ...

Market Chatter: EU Readies 'Robust' Response to New US Import Tariffs, EC Spokesman Says

MT Newswires Live
·
27 Mar

Merck (NYSE:MRK) Gains EC Approval For CAPVAXIVE® Amid Recent 7% Share Price Dip

Simply Wall St.
·
27 Mar

How to link your Aadhaar Card to your Voter ID: A step-by-step guide

ByHT News Desk
·
26 Mar

European Commission (EC) Approves Merck’s CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults

Business Wire
·
26 Mar

ECP Asset Management and EC Pohl & Co Cease Substantial Holding in Nanosonics Limited

TIPRANKS
·
26 Mar

Shell Invests in Gato do Mato to Drive Brazil's Pre-Salt Growth

Zacks
·
24 Mar

Is Bristol-Myers Squibb (BMY) Among the Cheap Stocks to Buy According to Billionaires?

Insider Monkey
·
23 Mar

Shell's Brazil Subsidiary Joins Consortium Developing Gato do Mato Offshore Project

MT Newswires Live
·
21 Mar

Press Release: InflaRx Reports Full Year 2024 Results and Highlights Key Achievements and Expected Milestones

Dow Jones
·
20 Mar

Rhythm Pharmaceuticals Announces Orphan Drug Designation Granted to Setmelanotide for Treatment of Hypothalamic Obesity in Japan

GlobeNewswire
·
20 Mar

EC World REIT Announces New Property Management Agreements

TIPRANKS
·
17 Mar

EC World Reit appoints new property managers, port operator

businesstimes
·
17 Mar

Bristol-Myers Squibb (NYSE:BMY) Gets EC Nod For Breyanzi In NHL Treatment

Simply Wall St.
·
15 Mar

Bristol Myers announces EC approval of Breyanzi

TIPRANKS
·
14 Mar

Bristol Myers Squibb Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma

Business Wire
·
14 Mar

Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 and Provides a Business Update

GlobeNewswire
·
14 Mar

Rxulti® (brexpiprazole) approved in the European Union for the treatment of schizophrenia in adolescents aged 13 years and older

PR Newswire
·
13 Mar

Geron Announces European Commission Approval of RYTELO® (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adults With Transfusion-Dependent Anemia Due to Lower-Risk MDS

Business Wire
·
12 Mar

Petrobras' Board Approves $283 Million Settlement Agreement

Zacks
·
11 Mar

Pertamina Crude Oil Corruption: AGO Interrogates Four Officials

Tempo
·
11 Mar